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ABSTRACT: Elongation factor (EF) Tu fromEscherichia colicontains three domains, of which domain 1
(N-terminal domain) harbors the site for nucleotide binding and GTP hydrolysis. To analyze the function
of domains 2 [middle (M) domain] and 3 [C-terminal (C) domain], EF-Tu(∆M) and EF-Tu(∆C) were
engineered as GST-fused products and purified. Circular dichroism and thermostability showed that both
constructs have conserved organized structures. Though inactive in poly(Phe) synthesis the two constructs
could bind GDP and GTP with comparable micromolar affinities. Therefore, like the isolated N-terminal
domain, they had lost a typical feature of EF-Tu, the>100 times stronger affinity for GDP than for GTP.
EF-Tu(∆M) and EF-Tu(∆C) had an intrinsic GTPase activity comparable to that of wild-type EF-Tu.
Ribosomes did not stimulate the GTPase activity of either factor, while kirromycin increased the GTPase
activity of both constructs, particularly of EF-Tu(∆C), to a level, however, much lower than that of the
intact molecule. The interaction with aa-tRNA of both mutants was>90% reduced. As a major result,
their GDP-bound form could efficiently respond to EF-Ts. All four EF-Tu-specific antibiotics [kirromycin,
pulvomycin, GE2270 A ()MDL 62 879), and enacyloxin IIa] retarded significantly the dissociation of
EF-Tu(∆C)·GTP, showing the same kind of effect as on EF-Tu‚GTP, but they were little active on EF-
Tu(∆M)‚GTP. Like EF-Tu(∆C)‚GTP, EF-Tu(∆M)‚GTP was, however, able to bind efficiently kirromycin
and enacyloxin IIa, as determined via competition with EF-Ts. Together, these results enlight selective
functions of domains 2 and 3, particularly toward the interaction with EF-Ts and antibiotics, and emphasize
their functional cooperativity for an efficient interaction of EF-Tu with ribosomes and aa-tRNA and for
maintaining the differential affinity for GTP and GDP.
In bacterial protein biosynthesis, the GTP-bound elonga-
tion factor Tu (EF-Tu)1 acts as the carrier of aa-tRNA to
the mRNA-programmed ribosome (Miller & Weissbach,
1977; Kaziro, 1978; Weijlandet al., 1992). The recycling
of EF-Tu‚GTP requires two events: the hydrolysis of GTP,
leading to the GDP-bound state with low affinity for aa-
tRNA and ribosomes, and the exchange of bound GDP and
free GTP, a reaction accelerated by EF-Ts. EF-Tu is the
target of four families of antibiotics: kirromycin, pulvomy-
cin, GE2270 A [for references, see Parmeggiani and Swart
(1985) and Anborgh and Parmeggiani (1991)], and enacy-
loxin IIa (Cetin et al., 1996). Kirromycin prevents the
dissociation of EF-Tu‚GDP from the ribosome‚aa-tRNA
complex; GE2270 A and pulvomycin inhibit the interaction
between EF-Tu‚GTP and aa-tRNA, and enacyloxin IIa
hinders the incorporation of aa-tRNA into polypeptidyl-tRNA
by acting on both EF-Tu and the ribosome.
Recently, the progress of our knowledge of the tertiary
structure of EF-Tu has helped in clarifying several aspects
of the interactions between EF-Tu and its ligands. X-ray
diffraction studies (Kjeldgaard & Nyborg, 1992; Berchtold
et al., 1993; Kjeldgaardet al., 1993, Polekhinaet al., 1996;
Abel et al., 1996) have revealed marked differences in the
orientations of the EF-Tu domainssparticularly of domains
2 and 3 toward domain 1sdepending on whether GDP or
GTP is bound. Moreover, they have shown that the binding
of aa-tRNA to EF-Tu‚GTP takes place in the interfaces
between domains 1 and 2 and domains 2 and 3 (Nissenet
al., 1995) and that the EF-Tu‚EF-Ts complex has the major
contact on domain 1 (Kawashimaet al., 1996).
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Site-directed mutagenesis has largely contributed to en-
lighten the structural-functional background of the EF-Tu
interactions. In particular, point substitutions in and around
the nucleotide binding pocket have outlined the properties
of this region [for references, see Weijlandet al. (1992)].
Concerning the functional role of the three domains, the
isolated domain 1 (G domain) ofEscherichia coliEF-Tu
was found to bind the nucleotide (Parmeggianiet al., 1987;
Jensenet al., 1989) and catalyze the hydrolysis of GTP, but
its activities were no longer exposed to regulatory constrains
induced by the various ligands. This suggested that domains
2 and 3 modulate the EF-Tu interaction with ligands. These
observations encouraged us to apply the mutagenic approach
to define the functions of the two noncatalytic domains. In
this work, we report on the characterization of twoE. coli
EF-Tu constructs lacking either domain 2 [EF-Tu)∆M)] or
domain 3 [EF-Tu(∆C)] and, in particular, on their role in
the interaction with ligands.
MATERIALS AND METHODS
Materials. Restriction enzymes, T4 DNA ligase, and calf
intestinal alkaline phosphate were from Boehringer, Mann-
heim; glutathione-Sepharose 4B was from Pharmacia-LKB;
human thrombin and reduced glutathione were from Sigma
Chemical Co. (St. Louis, MO). For other biological materials
see Parmeggiani and Sander (1981). Kirromycin, pulvomy-
cin, and GE2270 A ()MDL 62 879) were used as described
(Anborgh & Parmeggiani, 1991, 1993). Enacyloxin IIa,
obtained from Dr. K. Izaki (Tohoku University, Sendai,
Miyagi 982, Japan), was kept as a 10 mM stock solution in
100% methanol at-20 °C (Cetinet al., 1996).
Construction, Production, and Purification of Deleted EF-
Tu’s. Site-directed mutagenesis was carried out on theE.
coli tufAgene cloned in pEMBL9+, using synthetic oligode-
oxynucleotides (Parmeggianiet al., 1987). For constructing
EF-Tu(∆C), 5′-C ATC AAG CCG4GGC TAA TTG CA-3′
was used as mutagenic primer. Its 5′-half hybridized to
nucleotides 891-900 of tufA and its 3′-half to nucleotides
1177-1187, comprising the C-terminal Gly393, the termina-
tion codon, and five nucleotides of the C-terminal flanking
region. With this primer we could loop out the nucleotides
encoding His301 to Leu392, a region of the molecule
including the C-terminal domain of EF-Tu. For constructing
EF-Tu(∆M), the 5′-half of the mutagenic primer 5′-A GAG
CGT GCG4AAG CCG GGC A-3′ was hybridized to nucle-
otides 608-615 and its 3′-half to nucleotides 880-891,
looping out the nucleotides encoding Ile206 to Ala293 and
thus the middle domain. Both constructs were checked by
DNA sequence. TheMr’s of the two constructs are 32 907
[EF-Tu(∆C) and 33 483 [EF-Tu(∆M)].
To prepare theGSTfusions, the coding sequence oftu A
(or its deleted mutants) was inserted into the uniqueBamHI
site of pGEX-2T, under control of the IPTG-inducibletac
promoter (Smith & Johnson, 1988). TheBamHI site was
engineered upstream to the 5′-end of the first codon oftufA,
resulting in the in-frame fusion of theGSTand tufA gene.
Preserved at the fusion junction was the site for endopro-
teolytic cleavage by thrombin (Leu-Val-Pro-ArgVGly-Ser).
Since the Ser residue in this sequence corresponds to the
N-terminal Ser of EF-Tu, after cleavage the resulting EF-
Tu contains an additional N-terminal Gly. SDS-PAGE of
the crude cell extracts showed overproduction of a protein
with a Mr of ∼70 000, which corresponds to the expected
relative molecular mass for the GST-fused EF-Tu (Mr )
26 000+ 43 000), or of a protein with aMr of ∼60 000 in
the case of both fused mutants (Mr ) 26 000+ 33 000).
For purification of the various EF-Tu forms,E. coli cells
(10 g) were resuspended in 50 mL of buffer A (50 mM Tris-
HCl, pH 7.6, 60 mM KCl, 5 mM MgCl2, 10µM GDP, and
7 mM ME) containing 1 mM PMSF and sonicated on ice.
After centrifugation (30000g for 30 min), the supernatant
was applied to a prepacked glutathione-Sepharose 4B
column (2 mL), preequilibrated with buffer A. After a wash
with 20 mL of the same buffer, the elution was carried out
with 10 mL of buffer A, containing 5 mM reduced glu-
tathione. The next step was on an Ultrogel AcA44 column
(100 cm× 3 cm), preequilibrated and eluted with buffer A.
To cleave GST, thrombin (1µM/mL) in buffer A plus 2.5
mM CaCl2 was slowly passed on the GST-fused EF-Tu
bound to the affinity column at 4°C (flow rate: 0.5 mL/
min). The action of thrombin was stopped with 0.2 mM
PMSF.
Circular Dichroism Measurements.The circular dichro-
ism (CD) spectra of the various GST-fused products were
measured with a Jasco 710 spectropolarimeter (Japan Spec-
troscopic Co., Ltd., Tokyo) in a 0.1 cm cuvette at room
temperature and at a concentration of 0.15 mg of protein/
mL in 20 mM potassium phosphate buffer, pH 7.0, and 2
mM MgCl2. Since the proteins were diluted at least 10-
fold in the phosphate buffer, the remaining storage buffer
components (<1 mM ME and <5% glycerol) did not
interfere with CD measurements. Ten spectra were taken
for each protein and subsequently averaged. The mean
residue ellipticity [θ]m was calculated from the ellipticity (θ)
by the equation [θ]m ) (θ)/(nc), wheren indicates the number
of peptide bonds in the protein andc the molar concentration
of the protein.
Other Methods. For DNA sequencing by the dideoxy
chain-termination method, Sequenase 2.0 (USB) was used.
Plasmid purification, agarose gel electrophoresis, and DNA
transformation were performed by standard methods (Sam-
brooket al., 1990). Poly(Phe) synthesis (Jacquet & Parmeg-
giani, 1988), GDP or GTP dissociation rates and dissociation
constants (Fasanoet al., 1978; Parmeggianiet al., 1987;
Anborgh et al., 1993), spontaneous hydrolysis of Phe-
tRNAPhe (Cetin et al., 1996), equilibrium dialysis (Cre´chet
& Parmeggiani, 1986), and EF-Tu-dependent binding to
poly(U)‚ribosomes and native PAGE (Anborgh & Parmeg-
giani, 1991) were carried out as described. Hydrolysis of
[γ-32P]GTP was measured according to the charcoal method
(Ivell et al, 1981) and the complex between Phe-tRNAPhe
and the GTP-bound EF-Tu forms by filtration on Sephadex
G25 columns (0.37× 15 cm) (Créchet & Parmeggiani,
1986). In the experiments involving GTP, it was carefully
controlled that the presence of trace contaminations of
nucleotidases did not influence the reactions by affecting
critically the concentration of GTP. When needed, an excess
of ATP was added to damp down unspecific nucleotidase
activities. The standard buffer we referred to in the legends
to the figures was 50 mM Tris-HCl, pH 7.6, 60 mM NH4Cl,
10 mMMgCl2, and 1 mM DTT. The G-domain, the isolated
N-terminal domain of EF-Tu, was purified according to
Parmeggianiet al. (1987) and Jensenet al. (1989). Protein
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concentration was determined by the method of Bradford
(1976), using bovine serum albumin as standard.
RESULTS
Production of EF-Tu(∆C) and EF-Tu(∆M). Maximum
production of the recombinant protein was obtained after 3
h of induction at 30°C or 7 h at 24°C in the presence of
0.1-0.3 mM IPTG. In the cell extract, EF-Tu(∆C) and EF-
Tu(∆M) were 30-40% soluble, while EF-Tu was>80%
soluble. In the case of EF-Tu(∆M), it was important to keep
the induction temperature at 24°C. After affinity chroma-
tography, EF-Tu(∆C) or EF-Tu(∆M) were∼80% pure, as
tested on SDS-PAGE. The yield was∼85% of the initial
soluble product,i.e., 2-3.5 mg/g of induced cells at 2.0A600.
As shown in Figure 1, passage on Ultrogel AcA44 increased
the purification of EF-Tu(∆C) (lane 3) and EF-Tu(∆M) (lane
4) to∼90% and of EF-Tu (lane 2) to∼100%. GST could
be cleaved by thrombin digestion; unfortunately, release of
GST made the mutated proteins more prone to aggregation,
reducing markedly the yield. Therefore, since the presence
of GST did not appear to influence much the majority of
the EF-Tu activities, the mutated forms were used in most
experiments as GST fusions, unless otherwise stated, taking
GST-fused GlyEF-Tu as reference.
Circular Dichroism and Stability to Heat Denaturation.
In order to verify the influence of the deletion of domain 2
or 3 on the tertiary structure, the CD spectra of the two
mutated forms fused with GST were compared to the spectra
of GST-EF-Tu (Figure 2). As a first result, each product
showed a CD spectrum of a protein with a defined structure.
Furthermore, the percentage ofR-helical stretches was larger
in the two deletion mutants (208-222 nm), whereas the
signal around 203 nm, indicative for theâ-strand content,
was smaller in the mutants, as compared to the full-length
protein. These differences are to be expected since deletion
of the middle or of the C-terminal domain removes parts of
EF-Tu that contain onlyâ-strands. The spectrum of EF-
Tu(∆C) bears strong resemblance to that reported for the
corresponding construct [EF-Tu(I, II)] fromThermus ther-
mophilus(Nock et al., 1995).
Concerning the resistance to heat denaturation (Figure 3),
inactivation of GDP-bound EF-Tu(∆C) and G domain
occurred at lower temperature than that of the full-length
molecule (t50 ) 37 Vs 51 °C). EF-Tu(∆M)‚GDP (t50 ) 51
°C) was less stable than full-length EF-Tu between 42 and
51 °C and more stable at>52 °C. The border course of
inactivation of the mutated forms suggests a more pro-
nounced conformational heterogeneity than in the case of
EF-Tu.
EF-Tu(∆C) and EF-Tu(∆M) Are InactiVe in Poly(Phe)
Synthesis.GST-fused EF-Tu, though much less active in
poly(Phe) synthesis than unfused EF-Tu, showed a significant
activity (∼10% that of native EF-Tu or of thrombin cleaved
GlyEF-Tu, not shown). The presence of an additional
glycine at the N-terminus of EF-Tu was irrelevant for the
rate of poly(Phe) synthesis or any other activity of EF-Tu.
EF-Tu(∆C) and EF-Tu(∆M) were totally inactive in poly-
FIGURE1: SDS-PAGE patterns of unfused EF-Tu, GST-fused EF-
Tu, EF-Tu(∆C), and EF-Tu(∆M) after purification by GST affinity
and AcA44 gel filtration chromatography. Protein bands were
visualized by staining with Coomassie Brilliant Blue. Of each
protein, 1µg was applied. Lanes: (1) unfused EF-Tu; (2) fused
EF-Tu; (3) EF-Tu(∆C); (4) EF-Tu(∆M).
FIGURE 2: Circular dichroism of the various forms of EF-Tu: CD
signal of 0.15 mg/mL GDP-bound GST-fused products [EF-Tu (O),
EF-Tu(∆C) (2), and EF-Tu(∆M) (0)] in 20 mM potassium
phosphate buffer, pH 7.0, and 2 mM MgCl2 at room temperature
after determination of the molar residual ellipticity, [θ]m.
FIGURE 3: Temperature-induced denaturation of EF-Tu, EF-Tu-
(∆C), EF-Tu(∆M), and G domain. Twenty picomoles of GDP-
bound EF-Tu (O), EF-Tu(∆C) (2), EF-Tu(∆M) (0), or G domain‚
GDP (b), preincubated for 15 min at 30°C in 20µL of standard
buffer in the presence of 140 pmol of [3H]GDP (specific activity,
3100 dpm/pmol), was incubated for 8 min at the indicated
temperatures, cooled on ice, and then spotted on nitrocellulose
filters. The results are expressed as a percentage of the [3H]GDP
binding obtained upon incubation for 8 min at 0°C.
488 Biochemistry, Vol. 37, No. 2, 1998 Cetin et al.
(Phe) synthesis, even after cleavage of GST by thrombin
(not shown).
The Affinity for GDP Is the Most Affected Parameter in
the Guanine Nucleotide Interaction of Mutated EF-Tu’s.The
presence of GST did not essentially modify the nucleotide
interaction of full-length EF-Tu [Table 1;cf. also Fasanoet
al. (1978) and Scaranoet al. (1995)]. A typical property of
EF-Tu is its 2 orders of magnitude higher affinity for GDP
than for GTP. An important modification of the two mutated
forms is that the affinities for GDP and GTP both lie in the
micromolar range, a property also observed with the G
domain (Parmeggianiet al., 1987; Jensenet al., (1989). The
Kd value of the GDP complex of EF-Tu(∆C) and EF-Tu-
(∆M) has thus increased 3 orders of magnitudeVs that of
the full-length EF-Tu, whereas theKd of the GTP complex
has only increased 1 order of magnitude. Noteworthy, the
GDP off-rates of EF-Tu(∆C)·GDP and EF-Tu(∆M)‚GDP,
though faster than the off-rate of EF-Tu·GDP, are severalfold
slower than that of the G domain·GDP.
EF-Tu(∆C) and EF-Tu(∆M) Can Still Express an Intrinsic
GTPase ActiVity. Effect of Kirromycin and Ribosomes.EF-
Tu is endowed with a very low intrinsic GTPase activity
that can be specifically enhanced by ribosomes or kirromycin
(Fasanoet al., 1982). In studying the GTPase activity of
the two mutated EF-Tu’s, we observed the presence of trace
contaminations of nucleotidases (GTPases/ATPases), even
in our most purified preparations, especially with EF-Tu-
(∆M). Considering the very low activity of the intrinsic GTP
hydrolysis of EF-Tu (Fasanoet al., 1982), it was important
to neutralize this unspecific activity. Since the nucleotide
binding to EF-Tu is strictly specific for the guanine base, as
shown by 3D analysis (Jurnak, 1985, Kjeldgaard & Nyborg,
1992), we damped down the nucleotidase activity by adding
to our assay (i) high concentrations of KCl that, besides
increasing the intrinsic GTPase activity of EF-Tu (Fasano
et al., 1978; Ivellet al., 1981) or G domain (Jensenet al.,
1989), strongly inhibit nucleotidase activities (A. Parmeg-
giani, unpublished results) and (ii) high concentrations of
ATP. Moreover, we also tested the GTPase activity in the
presence of kirromycin, whose action is known to enhance
selectively the EF-Tu-dependent GTPase. The results show
that the GTPase activity, determined at concentrations of
GTP corresponding to a 50% saturation of wild-type EF-Tu
and the two mutated constructs, yields comparable values,
that of EF-Tu(∆C) being somewhat lower (Figure 4). The
presence of 50µM kirromycin enhanced the activity of wild
type ∼8 times, that of EF-Tu(∆C) ∼2 times, and that of
EF-Tu(∆M) ∼30%.
Unprogrammed ribosomes that efficiently stimulate the
intrinsic GTPase activity of full-length EF-Tu, whether fused
or unfused, and also slightly enhance the intrinsic GTPase
of the G domain (Jensenet al., 1989) were inactive on both
EF-Tu mutants (not shown).
The RemoVal of Either One of the Noncatalytic Domains
Strongly Weakens the Interaction with aa-tRNA.The ability
of the EF-Tu mutants to interact with aa-tRNA was
determined by (i) formation of a stable complex, (ii)
protection against spontaneous deacylation of aa-tRNA, and
(iii) binding of aa-tRNA to poly(U)-programmed ribosomes.
Since the half-life of the EF-Tu‚GTP complex is strongly
increased (>100 times) by the presence of aa-tRNA, the
stability of this interaction was determined by following the
migration of [γ-32P]GTP on Sephadex G25 gel filtration
columns (Cre´chet & Parmeggiani, 1986). As shown in
Figure 5A, in the presence of Val-tRNAVal the EF-Tu‚[γ-










EF-Tu‚GTP 0.8 138 6.9 0.2
GST-EF-Tu‚GTP 1.6 72 0.8 0.9
GST-EF-Tu(∆C)‚GTP 2 58 0.097 6
GST-EF-Tu(∆M)‚GTP 9 12.8 0.013 10
G domain‚GTP 1 115 0.18 6.2b
EF-Tu‚GDP 80 1.4 7.2 0.002
GST-EF-Tu‚GDP 68 1.7 8.5 0.002
GST-EF-Tu(∆C)‚GDP 12 9.6 0.046 2.1
GST-EF-Tu(∆M)‚GDP 20 5.8 0.019 3
G domain‚GDP 4 29 0.13 2.1b
aDetermined at 0°C. Association rate constants were determined ask+1 ) k-1/Kd. b Taken from Jensenet al. (1989).
FIGURE 4: Intrinsic GTPase activity of EF-Tu, EF-Tu(∆C), and
EF-Tu(∆M) and effect of kirromycin. Reaction mixtures (200µL)
containing 50 mM imidazolium acetate, pH 7.5, 2 M KCl, 10 mM
MgCl2, 1 mM DTT, 2 mM PEP, 40µg/mL PK, 200µM ATP, and
1 µM EF-Tu (circles), EF-Tu(∆C) (triangles), or EF-Tu(∆M)
(squares) were incubated for 20 min at 30°C. After a further 5
min incubation without (open symbols) or with (closed symbols)
50 µM kirromycin at 30°C, the reaction preceded by addition of
0.9, 6, and 10µM [γ-32P]GTP for EF-Tu, EF-Tu(∆C), and EF-
Tu(∆M), respectively (specific activity, 1500 dpm/pmol). At the
indicated times, aliquots (20µL) were withdrawn and the liberated
[γ-32P]Pi was determined.
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32P]GTP formed a discrete peak preceding the free [γ-32P]-
GTP, while in its absence EF-Tu-bound [γ-32P]GTP was not
detectable. With the mutant EF-Tu’s only a small amount
of bound [γ-32P]GTP preceded the free [γ-32P]GTP, corre-
sponding to∼9% [EF-Tu(∆M), Figure 5B] and∼5% [EF-
Tu(∆C), Figure 5C] of that bound to full-length EF-Tu.
In experiments not illustrated, neither EF-Tu(∆M) nor EF-
Tu(∆C) in complex with GTP could influence the rate of
the spontaneous deacylation of Phe-tRNAPhe, differently from
EF-Tu. This shows that the interaction between the EF-Tu
variants and the aminoacylated 3′-end of aa-tRNA is
anomalous.
Furthermore, whereas EF-Tu‚GTP strongly enhanced the
binding of Phe-tRNAPhe to poly(U)‚ribosomes (from about
10% in its absence to>90%), only a very low EF-Tu(∆M)-
or EF-Tu(∆C)-dependent stimulation of the Phe-tRNAPhe
binding could be detected, corresponding to 5-8% that
induced by EF-Tu‚GTP (Figure 6). These results are in
agreement with the reduced capability of the deleted EF-
Tu’s to form a stable complex with aa-tRNA (see above).
EF-Ts Interacts Efficiently with GDP-Bound EF-Tu(∆C)
andEF-Tu(∆M). The action of EF-Ts on the mutant EF-
Tu was determined by measuring the exchange rate of EF-
Tu-bound [3H]GDP or [3H]GTP with the corresponding free
unlabeled nucleotide (Figure 7). The addition of EF-Ts
(closed symbols with dashed lines) in a 1:100 molar ratio
markedly decreased the half-life of EF-Tu(∆C)‚GDP (panel
7B) and EF-Tu(∆M)‚GDP (panel 7C) to values comparable
to those obtained with EF-Tu. If the GDP release was
estimated by taking into account the higher (∼2 times)
intrinsic GDP/GDP exchange of the two mutants (Table 1),
the effect of EF-Ts on EF-Tu(∆M) was about half and that
on EF-Tu(∆C) one-third of the stimulation on the control
EF-Tu. Addition of more EF-Ts to a 1:1 molar ratio to EF-
Tu further increased the velocity of the dissociation rate
without essentially affecting the difference between mutated
forms and wild-type factor. EF-Ts did not enhance the
dissociation rate of G domain‚GDP, which is intrinsically
much faster than that of full-length EF-Tu and also of the
two mutated forms.
Remarkably, we were unable to detect any effect of EF-
Ts on the dissociation rate of EF-Tu(∆C)‚GTP and EF-Tu-
(∆M)‚GTP even if EF-Ts was added to a 2:1 molar excess
(not shown).
EF-Tu-Specific Antibiotics Are ActiVe on GTP-Bound EF-
Tu(∆C). A common effect of the action of the EF-Tu-
specific antibiotic is the strong retardation of the EF-Tu‚
GTP dissociation rate (Parmeggiani & Swart, 1985; Anborgh
& Parmeggiani, 1993; Cetinet al., 1996). Therefore, the
dissociation rate of the GTP complex is the most representa-
tive parameter for analyzing the response to antibiotics of
the mutated EF-Tu’s. As shown in Figure 8, kirromycin,
pulvomycin, GE2270 A, and enacyloxin IIa were able to
retard consistently the dissociation rate of EF-Tu(∆C)‚GTP
from 4- to 7-fold, depending on the kind of antibiotic. With
FIGURE 5: Formation of a stable complex between Val-tRNAVal and EF-Tu, EF-Tu(∆C), or EF-Tu(∆M). The reaction mixtures contained,
in 30 µL of standard buffer, 1µM EF-Tu(A), EF-Tu(∆M) (B), or EF-Tu(∆C) (C), 5µM [γ-32P]GTP (specific activity, 3500 dpm/pmol),
1 mM PEP, and 40µg/mL PK incubated at 10 min at 30°C in the absence (open symbols) or presence (closed symbols) of 5µM Val-
tRNAVal and were subsequently passed onto a Sephadex G25 column (0.37× 15 cm) equilibrated with standard buffer. Fractions (100µL)
were collected and the radioactivity was determined.
FIGURE 6: Enzymatic binding of [14C]Phe-tRNAPhe to the A-site
of poly(U)-programmed ribosomes mediated by EF-Tu, EF-Tu-
(∆C), or EF-Tu(∆M). The reaction mixture (20µL) contained 25
mM Tris-HCl, pH 7.6, 86 mM NH4Cl, 10 mM MgCl2, 7 mM ME,
1 mM ATP, 0.25 mM GTP, 1 mM PEP, PK (40µg/mL), 0.5µM
ribosomes poly(U) (80µg/mL), 0.5µM tRNAPhe, 0.7 µM [14C]-
Phe-tRNAPhe (specific activity, 584 dpm/pmol), and 1µM EF-Tu
(O), EF-Tu(∆C) (2), EF-Tu(∆M) (0) or no enzyme (b). The
diverse EF-Tu’s in complex with GTPwere preincubated with [14C[]-
Phe-tRNAPheand the ribosomes with tRNAPheand poly(U), for 10
min at 30°C. The reaction was initiated by the addition of the
poly(U)-programmed ribosomes. The binding of [14C]Phe-tRNAPhe
to the ribosomal A-site was determined by the nitrocellulose binding
assay.
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enacyloxin IIa, the increase in half-life of EF-Tu(∆C)‚GTP
was∼50% that of the control EF-Tu, with kirromycin∼30%,
and with pulvomycin and GE2270 A 5-10% (cf. panel B
with A). Much lower was the effect of the antibiotics on
EF-Tu(∆M) (Figure 8C). Enacyloxin IIa retarded it 10 times
less than in the case of EF-Tu(∆C), and with the other three
antibiotics the effect was scarcely significant. The half-life
of the G domain‚GTP complex displayed a minimal response,
if any (Figure 8D). These results show selective differences
between EF-Tu(∆C) and EF-Tu(∆M) in the response to
antibiotics.
Kirromycin and Enacyloxin IIa Compete with EF-Ts for
Binding to EF-Tu(∆C) and EF-Tu(∆M) in Complex with
GDP. It has long been known that EF-Ts and kirromycin
compete for binding to EF-Tu. This property has been used
to remove this antibiotic from EF-Tu by means of a dialysis
of EF-Tu‚kirromycin in the presence of EF-Ts (Swartet al.,
1987; Anborgh & Parmeggiani, 1993). Of the other three
EF-Tu-specific antibiotics, only enacyloxin IIa can compete
with EF-Ts for binding to EF-Tu like kirromycin (Cetinet
al., 1996). Therefore, we tested whether EF-Ts and these
two antibiotics were still able to compete for binding to the
two mutated EF-Tu forms. The experiments illustrated in
Figure 9 show that this competition can take place with both
mutants, in a remarkably similar manner. In fact, kirromycin
and enacyloxin IIa were able to decrease to a comparable
extent the stimulation by EF-Ts of the GDP dissociation rate
from both EF-Tu(∆M) and EF-Tu(∆C). This shows that the
two antibiotics can efficiently bind to the GDP-bound form
of EF-Tu(∆M) despite the fact that its GTP-induced con-
formation was found to be near-irresponsive to their action.
DISCUSSION
The aim of this work was to fill the gap in our knowledge
of the functions of domains 2 and 3 of EF-Tu, by engineering
intermediary constructs between G domain and full-length
EF-Tu. Since the G domain has nearly completely lost the
ability to respond to the action of high molecular weight
ligands or antibiotics (Parmeggianiet al., 1987), it was
reasonable to assume that the two noncatalytic domains
control the regulation of EF-Tu activities by ligands. Our
results show that, despite the deletion of an entire noncata-
lytic domain, both mutated forms are still able to interact
with GTP and GDP, as has been found for the G domain
(Parmeggianiet al., 1987). They also catalyze the hydrolysis
of GTP and can sustain the interactions with ligands, such
FIGURE 7: Action of EF-Ts on the GDP dissociation rates of EF-
Tu, EF-Tu(∆C), EF-Tu(∆M), and G domain. A 0.5µM quantity
of EF-Tu (A), EF-Tu(∆C) (B), EF-Tu(∆M) (C), or the G domain
(D) was incubated in 400µL of standard buffer containing 2.5µM
[3H]GDP (specific activity, 4400 dpm/pmol) for 15 min at 30°C.
After a further incubation for 5 min at 0°C in the absence (open
symbols) or in the presence of EF-Ts (closed symbols) at a
concentration of either 0.5 (solid line) or 0.005µM (dashed line),
the dissociation reaction was started by the addition of a 1000-fold
excess of cold GDP at 0°C. At the indicated times, aliquots (40
µL) were withdrawn, and the EF-Tu-bound radioactivity was
determined by the nitrocellulose binding assay.c0 represents the
initial concentration of the EF-Tu‚nucleotide complex andct the
concentration at the timet.
FIGURE 8: Influence of the EF-Tu-specific antibiotics on the
dissociation rate of the complex between GTP and EF-Tu, EF-Tu-
(∆C), EF-Tu(∆M), or G domain. The reaction mixture (400µL
of standard buffer) containing 1µM EF-Tu (A), EF-Tu(∆C) (B),
EF-Tu(∆M) (C), or G domain (D), 2.5µM [3H]GTP (specific
activity, 12000 dpm/pmol), 2.5 mM ATP, 1 mM PEP, 40µg/mL
PK, and 1 mM DTT was incubated for 15 min at 30°C and then
for 5 min at 0°C in the absence (A,O; B, 2; C,0; D, b) or in the
presence of 50µM kirromycin ([), pulvomycin (]), GE2270 A
(+), or enacyloxin IIA (×). The dissociation reaction was initiated
by the addition of a 1000-fold excess of unlabeled GTP. At the
indicated times, aliquots (40µL) were withdrawn, and the EF-Tu-
bound radioactivity was determined by the nitrocellulose binding
assay.
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as antibiotics and EF-Ts. The existence of a functionally
active conformation and of selective properties dependent
on whether the middle or the C-terminal domain is deleted
supports the presence in both EF-Tu mutants of a folding
close to that of the intact molecule. This agrees with NMR
studies of Lowryet al. (1991) showing the conservation of
an organized structural folding in the nucleotide binding
region of the G domain even after removal of both noncata-
lytic domains. Also, the CD spectra of EF-Tu(∆M) and EF-
Tu(∆C) indicate that the organization of the secondary
structural elements of the two EF-Tu mutants is not dramati-
cally changed. EF-Tu(∆M) displays a thermostability close
to that of the intact molecule whereas EF-Tu(∆C) resembles
the G domain. It was important to verify whether the relative
orientation of domains 1 and 3 in EF-Tu(∆M) was not
markedly altered. Therefore, in addition to functional tests
we carried out a model building (Figure 10A) of the
orientation and folding of these two domains after looping
out residues 206-293. Using the 3D model of EF-Tu‚
GMPPNP fromThermus aquaticus(PDB database), we
removed the residues from V217 (I206 inE. coli EF-Tu) to
K306 (K294 inE. coli EF-Tu), after which energy minimiza-
tion was applied. Our results show that the interaction forces
between domains 1 and 3 of EF-Tu are strong enough to
preserve the interface of these two domains, avoiding a
significant displacement of the relative orientation and
distance. Nor did we observe a significant difference in the
folding of the two domains as shown by superimposition
with the corresponding domains of the full-length EF-Tu.
Another conclusion is that the resulting joining loop (11
residues between 201-205 and 294-299) connecting do-
main 1 (residues 4-200) and domain 3 (residues 300-393)
after the deletion of the middle domain is long enough to
span the distance between the two residual domains. To-
gether, these observations show that all the individual
domains of EF-Tu constitute remarkably stable conforma-
tional entities, capable of sustaining specific activities. This
justifies their use, individually or in combination, to analyze
the structural-functional relationships of EF-Tu in the
interactions with ligands.
The affinities of EF-Tu(∆C) and EF-Tu(∆M) for GDP and
GTP lie in the micromolar range and are comparable to those
reported for the G domain (Parmeggianiet al., 1987). As
has been shown for the G domain, the removal of either one
of the two domains mainly influences the GDP-bound state
of EF-Tu, decreasing the affinity for this nucleotide∼1000
times. These results suggest that the nucleotide binding
pocket in the two mutants, independently of the presence of
GTP or GDP, has an open conformation resembling that of
EF-Tu‚GTP, whose affinity for the nucleotide is more than
100-fold less strong than for GDP. Thus, a typical feature
of EF-Tu, the differential affinity for GTP and GDP, results
from cooperative effects involving all three domains. Note-
worthy, the half-life of the GDP complex of the two
FIGURE 9: Kirromycin (I ) and enacyloxin IIa (II ) compete with EF-Ts for binding to EF-Tu(∆C) and EF-Tu(∆M). EF-Tu‚GDP (A),
EF-Tu(∆C) (B), or EF-Tu(M) (C) (0.10µM) was incubated in 400µL of standard buffer containing 0.12µM [3H]GDP (specific activity,
11000 dpm/pmol) for 15 min at 30°C. After the additional incubation for 5 min at 0°C in the presence of kirromycin or enacyloxin IIa
(dashed lines) or in the absence of antibiotics (solid lines), with 0.01µM EF-Ts (closed symbols) or without EF-Ts (open symbols), the
dissociation reaction was initiated by the addition of a 1000-fold excess of cold GDP at 0°C. At the indicated times, aliquots (40µL) were
withdrawn, and the EF-Tu-bound radioactivity was determined by the nitrocellulose binding assay.
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constructs is intermediary between that of the G-domain and
of the intact molecule, suggesting a stabilization effect by
each of the two noncatalytic domains. In the case of EF-
Tu(∆M), this can be rationalized in terms of the 3D model,
where domain 3 appears to stabilizeR-helices B and C in
the N-terminal domain.
The intrinsic GTPase activity of EF-Tu(∆M) was found
to be similar to that of wild-type EF-Tu; that of EF-Tu(∆C)
slightly decreased. Also, the stimulation by kirromycin is
still present, though it is lower particularly in the case of
deletion of the middle domain.
No stimulatory effect by ribosomes was observed on the
intrinsic GTPase activity of the two mutated EF-Tu’s. This
was rather surprising, because ribosomes can slightly enhance
the GTPase activity of the G domain (Parmeggianiet al.,
1987; Jensenet al., 1989). The lack of an effect may be
related to negative long-range changes induced by the
residual noncatalytic domain on domain 1.
Either one of the mutated forms can form a stable complex
with aa-tRNA but only to an extent<10% that of EF-Tu,
whereas no binding of aa-tRNA can take place on the G
domain (Parmeggianiet al., 1987). These findings empha-
size the importance of all three domains for an efficient
binding of aa-tRNA. Cross-linking and protection studies
suggested that the aminoacylated CCA 3′-end of tRNA
interacts with domains 1 and 2 (Jona´k et al., 1980, 1984;
Metz-Boutigueet al., 1989; Van Noortet al., 1984). The
3D model of Phe-tRNAPhe-bound T. aquaticus EF-Tu‚
GppNHp (Nissenet al., 1995) shows that the binding site
of the aminoacylated acceptor helix of tRNA is located in
the interfaces of the three domains. The combination ofE.
coli (Pieperet al., 1990) orT. thermophilus(Peteret al.,
1990) middle and C-terminal domains was unable to interact
with aa-tRNA. For poly(Phe) synthesis, our results show
that both noncatalytic domains of EF-Tu are required, as
expected from the complexity of this process involving
multiple steps and the formation of highly selective com-
plexes.
A major result of this study was the finding that EF-Ts
can stimulate efficiently to a comparable extent the release
of GDP from both mutated constructs. Observation based
on point substitutions (Hwanget al., 1992) suggested that
the region of domain 1 comprising residues 154-195
interacts with EF-Ts. Peteret al. (1990) reported that the
two noncatalytic domains interact with EF-Ts, since EF-Ts
could retard the electrophoretic mobility ofT. thermophilus
EF-Tu lacking domain 1. The elucidation of the 3D structure
of EF-Tu‚EF-Ts (Kawashimaet al., 1996) shows that the
most extensive contact between the two proteins takes place
on domain 1. Several structures are involved, such as the
phosphate binding loop, the amino terminus of helix Bstightly
associated with domain 3sand the helices C and D. Besides
domain 1, only the tip of domain 3 appears to interact directly
with EF-Ts. The observation that at least one noncatalytic
domain is required for a productive interaction between EF-
Tu and EF-Ts indicates that both noncatalytic domains are
FIGURE 10: (A) The relative orientation of domains 1 and 3 is essentially conserved in the EF-Tu(∆M) construct. The coordinates of the
T. aquaticusEF-Tu‚GMPPNP model were obtained from the PDB database. Using a Quanta software package, residues V217-K306
(corresponding to I206 and K294, respectively, inE. coli EF-Tu) were removed, after which energy minimization was applied using the
CHARMM22.0 force field. Color codes: full-length EF-Tu, blue; EF-Tu(∆M), yellow (domain 1) and red (domain 3). (B) A model
outlining possible regions of EF-Tu‚GTP involved in the binding sites for antibiotics. This schematic representation has been derived from
(i) comparative analyses of the actions of the antibiotics, (ii) the location of residues inducing resistance toward kirromycin (L120, Q124,
Y160, G316, Q329, A375, and E378), pulvomycin (R230, R230/R233, R333, and T334), and possibly GE2270 A (V226, see Discussion),
and (iii) the properties of the respective mutants. Pulvomycin and GE2270 A both abolish the interaction between EF-Tu and aa-tRNA
taking place in the interfaces between domains 1 and 2 and domains 2 and 3; kirromycin and particularly enacyloxin IIa affect negatively
the protection by EF-Tu of the aminoacylated N-terminal end of tRNA. Only kirromycin can enhance significantly the intrinsic GTPase
activity of EF-Tu.
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involved in inducing the active conformation of domain 1
responsive to EF-Ts. In fact, the G domain‚GDP complex
shows an intrinsic dissociation activity much higher than that
of EF-Tu(∆C) and EF-Tu(∆M) (cf. Figure 7, panel D with
panels B and C). A regulatory indirect function of domain
2 is supported by the absence in the 3D model of contacts
between this domain and EF-Ts (Kawashimaet al., 1996).
The physiological nature of the response to EF-Ts of the
two mutated EF-Tu forms is further supported by the partial
inhibition by kirromycin and enacyloxin IIa of the GDP
release induced by EF-Ts, a specific effect typical for full-
length EF-Tu.
The observation that EF-Ts is unable to enhance the
dissociation of the GTP complex of the mutants suggests
that the differential affinity of EF-Ts for the GTP- and GDP-
bound forms of the constructs has become much larger than
that of EF-Tu wild type. Indeed, the dissociation rate of
EF-Tu‚GTP is a few times less sensitive to EF-Ts than EF-
Tu‚GDP (Fasanoet al., 1978).
Selective effects have been found in this work, as to the
action of antibiotics on the two mutated EF-Tu’s. EF-Tu-
(∆C)‚GTP was much more responsive than EF-Tu(∆M)‚GTP
to all four EF-Tu-specific antibiotics, showing a response
of the same kind as the full-length molecule. Site-directed
mutagenesis has shown that the substitutions conferring
kirromycin resistance concern residues L120, Q124, and
Y160 on domain 1 and G316, Q329, E378, T357, and A375
on domain 3 (Parmeggiani & Swart, 1985; Mesterst al.,
1994; Abdulkarimet al., 1994). Functional and structural
analyses have led to the conclusion that the interface of
domain 1 with domain 3, whose extention is markedly
different in the GDP- and GTP-bound forms of EF-Tu,
harbors the binding site for kirromycin, very likely involving
Q124 (Mesterset al., 1994). Our results show that even
after removal of domain 3 kirromycin can still interact with
EF-Tu, with an efficiency stronger than after removal of
domain 2. Hence, the presence of domain 2 is crucial for
inducing an active binding site for kirromycin on domain 1.
Moreover, the inhibition of the action of EF-Ts on EF-Tu-
(∆M)‚GDP shows that kirromycin can tightly bind to domain
1 in the absence of domain 2. One can conclude that the
two noncatalytic domains act by concurring directly (domain
3) or indirectly (domain 2) to the activation of the kirromycin
binding site on domain 1. The ability of EF-Tu(∆M)‚GDP
to support specific effects such as the action of EF-Ts and
the response to kirromycin and enacyloxin IIa shows that
the selective properties of the two mutated constructs are a
consequence of the removal of specific structures and not
the result of an unspecific conformational disorder. Ad-
ditional information on the role of both noncatalytic domains
in the interaction of EF-Tu with kirromycin might become
available soon, since the complex EF-Tu‚kirromycin has been
crystallized recently (Kristensenet al., 1996).
Although enacyloxin IIa-resistant mutants of EF-Tu have
as yet to be isolated, the similarities of its action on EF-Tu
and EF-Tu‚EF-Ts to that of kirromycin suggest that its
binding site also involves the interface between domains 1
and 3 and is likely situated on domain 1. The location of
the binding sites for kirromycin and enacyloxin IIa in a
domain interface could explain the ability of the two
antibiotics to deregulate all the interactions between EF-Tu
and the various ligands by modifying the relative orientation
of two domains and thus of the overall conformation of the
molecule.
The residues, whose substitution induces pulvomycin
resistance (R230 and R230/R233 on domain 2, R333 and
T334 on domain 3; Zeefet al., 1994; Boonet al., 1995), are
located in the interfaces of the three domains of EF-Tu. Even
though structural considerations make uncertain that these
residues are part of the binding site for pulvomycin (Zeeft
al., 1995), the lack of response of EF-Tu(∆M) to pulvomycin
and the probable existence of distinct binding sites for
pulvomycin and kirromycin (Pingoudet al., 1982) and of
hindrance phenomena between aa-tRNA and pulvomycin
appear to favor a location of the binding site for pulvomycin
close to the domain 2/domain 3 interface.
Shimanakaet al. (1995) have isolatedBacillus subtilisEF-
Tu mutated in V228A (corresponding to V226 inE. coli EF-
Tu) resistant to amythiamicin, an antibiotic whose structure
is closely related to GE2270 A. We have found that GE2270
A efficiently retards the dissociation rate of EF-Tu(∆C)‚GTP,
without affecting that of EF-Tu(∆M), like pulvomycin, and
have also observed that GE2270 A induces a band shift of
EF-Tu(∆C) during nondenaturing PAGE (P. H. Anborgh,
unpublished observations). These results, together with the
similarity of its action with that of pulvomycin, suggest that
the GE2270 A binding site also involves the middle and
C-terminal domain of EF-Tu.
Figure 10B illustrates the probable locations on EF-Tu‚
GTP of the binding sites for antibiotics, as derived from our
present knowledge of the properties of EF-Tu mutants.
When this work was in progress, Nocket al. (1995)
described the properties ofT. thermophilusEF-Tu lacking
domain 3. This construct showed a similar affinity for GDP
and GTP, like the corresponding G domain and ourE. coli
EF-Tu(∆C). The presence of domain 2 increased the
thermostability ofT. thermophilusdomain 1 and even more
markedly the intrinsic GTPase activity of this domain, two
effects that we could not observe withE. coli EF-Tu(∆C).
Moreover,T. thermophilusEF-Ts was inactive onT. ther-
mophilusEF-Tu(I, II). At present, it is not possible to
explain these differences that may be, at least in part, related
to the intrinsic properties ofT. thermophilusEF-Tu and EF-
Ts or the specific experimental conditions used.
In conclusion, our work outlines selective effects on
domains 2 and 3 of EF-Tu in the action of antibiotics and
EF-Ts and emphasizes their cooperative function in the
interaction with ribosomes and aa-tRNA and in the dif-
ferential affinity for GTP and GDP. The removal of either
one of the noncatalytic domains has revealed effects, whose
structural background is not always clear. In fact, in the
3D model only domain 3 interacts with EF-Ts; however, EF-
Tu(∆C) induces a functional response to EF-Ts as EF-Tu-
(∆M) and EF-Tu wt, unlike the isolated domain 1 EF-
Tu(∆C) responds to kirromycin more efficiently than EF-
Tu(∆M) though the binding of the antibiotic is very likely
situated in the domain 1/domain 3 interface. These results
support the existence of long-range effects that cannot yet
be explained by the static configuration of the to date 3D
models and suggest caution in interpreting functional ob-
servations on the basis of our present structural knowledge.
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